Drug Shortage Report for PAMIDRONATE DISODIUM FOR INJECTION
Report ID | 202767 |
Drug Identification Number | 02244552 |
Brand name | PAMIDRONATE DISODIUM FOR INJECTION |
Common or Proper name | PAMIDRONATE DISODIUM FOR INJECTION |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | PAMIDRONATE DISODIUM |
Strength(s) | 9MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10mL vial |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-14 |
Estimated end date | |
Actual end date | 2024-04-30 |
Shortage status | Resolved |
Updated date | 2024-05-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-08-23 | English | Compare |
v2 | 2023-08-23 | French | Compare |
v3 | 2023-10-05 | English | Compare |
v4 | 2023-10-05 | French | Compare |
v5 | 2023-11-30 | English | Compare |
v6 | 2023-11-30 | French | Compare |
v7 | 2023-12-23 | English | Compare |
v8 | 2024-01-18 | English | Compare |
v9 | 2024-01-18 | French | Compare |
v10 | 2024-02-15 | English | Compare |
v11 | 2024-02-15 | French | Compare |
v12 | 2024-02-15 | English | Compare |
v13 | 2024-02-15 | French | Compare |
v14 | 2024-03-22 | English | Compare |
v15 | 2024-03-22 | French | Compare |
v16 | 2024-04-18 | English | Compare |
v17 | 2024-04-18 | French | Compare |
v18 | 2024-04-30 | English | Compare |
v19 | 2024-04-30 | French | Compare |
v20 | 2024-05-01 | English | Compare |
Showing 1 to 20 of 20